| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1182/BLOOD-2014-10-567461 |
| P8608 | Fatcat ID | release_ymp7dyhi6nf4pn67gfxzb5nfvy |
| P698 | PubMed publication ID | 25869285 |
| P2093 | author name string | G. Hapgood | |
| K. J. Savage | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 17-25 | |
| P577 | publication date | 2015-07-02 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | The biology and management of systemic anaplastic large cell lymphoma | |
| P478 | volume | 126 |
| Q64953373 | A genomic atlas of systemic interindividual epigenetic variation in humans. |
| Q46603813 | ALK Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy |
| Q47575958 | ALK expression plays different roles in anaplastic large-cell lymphomas and outcome of crizotinib use in relapsed/refractory ALK+ patients in a Chinese population |
| Q90024639 | ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients |
| Q48206638 | An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphoma |
| Q38651962 | Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma Manifesting as a Scalp Hematoma After an Acute Head Injury-a Case Report and Literature Review |
| Q48528844 | Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects. |
| Q57802242 | Breast Implant-Associated Anaplastic Large Cell Lymphoma |
| Q33769443 | Breast Implant-Associated Anaplastic Large Cell Lymphoma (ALCL): A Case Report |
| Q58126828 | Breast Implant-Associated Lymphoma |
| Q49282959 | Brentuximab vedotin: clinical updates and practical guidance |
| Q64055595 | Challenges of driving CD30-directed CAR-T cells to the clinic |
| Q40519524 | Clinical features and treatment outcome of Epstein-Barr virus-positive nodal T-cell lymphoma |
| Q30240160 | Diagnostic, prognostic and therapeutic role of CD30 in lymphoma |
| Q30239728 | Enteropathy-Associated T-Cell Lymphoma |
| Q47196130 | Epigenetic supersimilarity of monozygotic twin pairs |
| Q42199612 | Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency |
| Q39183278 | Genetic Landscape and Classification of Peripheral T Cell Lymphomas |
| Q64039313 | Interdigitating dendritic cell sarcoma of the spleen with hepatic failure after chemotherapy: A case report |
| Q92220876 | Leukemic phase of ALK-negative anaplastic large cell lymphoma in a patient who is on androgenic steroids: A case report |
| Q51567596 | Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel finding. |
| Q60685322 | Modernizing Clinical Trial Eligibility: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Minimum Age Working Group |
| Q37708848 | Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes. |
| Q52561814 | Mut2Vec: distributed representation of cancerous mutations. |
| Q91413856 | Outcome of patients with relapsed or refractory anaplastic large cell lymphoma who have failed brentuximab vedotin |
| Q38700613 | Partial deletion of the ALK gene in ALK-positive anaplastic large cell lymphoma. |
| Q40144667 | Primary Gastric ALK-negative EBV-negative Anaplastic Large Cell Lymphoma Presenting with Iron Deficiency Anemia |
| Q36675069 | Redundant and nonredundant roles for Cdc42 and Rac1 in lymphomas developed in NPM-ALK transgenic mice |
| Q103028768 | STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma |
| Q48172795 | The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group study. |
| Q98386532 | The expressions of MUM-1 and Bcl-6 in ALK-negative systemic anaplastic large cell lymphoma with skin involvement and primary cutaneous anaplastic large cell lymphoma |
| Q33567012 | The heterogeneous landscape of ALK negative ALCL. |
| Q89983793 | The novel lncRNA BlackMamba controls the neoplastic phenotype of ALK- anaplastic large cell lymphoma by regulating the DNA helicase HELLS |
| Q91265581 | The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study |
| Q52667696 | Update on the Treatment of Anaplastic Large Cell Lymphoma. |
| Q50016383 | Updates of Peripheral T Cell Lymphomas Based on the 2017 WHO Classification |
| Q39155963 | Use of brentuximab vedotin as salvage therapy pre-allogeneic stem cell transplantation in relapsed/refractory CD30 positive lympho-proliferative disorders: a single centre experience |
| Q90068118 | [Outcomes of 33 patients with anaplastic large cell lymphoma treated after hematopoietic stem cell transplantation] |
Search more.